AusPAR: Imfinzi

Australian Public Assessment Report

AusPAR

AusPAR: Imfinzi [PDF, 609.54 KB]

AusPAR: Imfinzi [Word, 1.37 MB]

Attachment Product information for Imfinzi [PDF, 885.87 KB]

Attachment Product information for Imfinzi [Word, 1.07 MB]

Device/Product Name

Imfinzi

Active ingredients

Durvalumab

AusPAR Date

8 December 2023

Published

20 December 2023

Submission Number

PM-2022-01573-1-4

Submission Type

Extension of indications

Decision

Approved